{"doc_id": "32665394", "type of study": "Therapy", "title": "", "abstract": "Advance Care Planning: Promoting Effective and Aligned Communication in the Elderly (ACP-PEACE): the study protocol for a pragmatic stepped-wedge trial of older patients with cancer.\nAdvance care planning (ACP) is associated with improved health outcomes for patients with cancer, and its absence is associated with unfavourable outcomes for patients and their caregivers.\nHowever, older adults do not complete ACP at expected rates due to patient and clinician barriers.\nWe present the original design, methods and rationale for a trial aimed at improving ACP for older patients with advanced cancer and the modified protocol in response to changes brought by the COVID-19 pandemic.\nMETHODS AND ANALYSIS : The Advance Care Planning: Promoting Effective and Aligned Communication in the Elderly study is a pragmatic, stepped-wedge cluster randomised trial examining a Comprehensive ACP Program.\nThe programme combines two complementary evidence-based interventions: clinician communication skills training (VitalTalk) and patient video decision aids (ACP Decisions).\nWe will implement the programme at 36 oncology clinics across three unique US health systems.\nOur primary outcome is the proportion of eligible patients with ACP documentation completed in the electronic health record.\nOur secondary outcomes include resuscitation preferences, palliative care consultations, death, hospice use and final cancer-directed therapy.\nFrom a subset of our patient population, we will collect surveys and video-based declarations of goals and preferences.\nWe estimate 11 000 patients from the three sites will be enrolled in the study.\nETHICS AND DISSEMINATION : Regulatory and ethical aspects of this trial include Institutional Review Board (IRB) approval via single IRB of record mechanism at Dana-Farber Cancer Institute, Data Use Agreements among partners and a Data Safety and Monitoring Board.\nWe plan to present findings at national meetings and publish the results.\nTRIAL REGISTRATION NUMBER : NCT03609177; Pre-results.\n\u00a9 Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC.\nNo commercial re-use. See rights and permissions.\nPublished by BMJ.\n", "Evidence Map": {"Enrollment": [{"term": "Planning", "negation": "affirmed", "UMLS": {}, "start": 13, "end": 21}, {"term": "older adults", "negation": "affirmed", "UMLS": {}, "start": 10, "end": 22}, {"term": "older patients", "negation": "affirmed", "UMLS": {}, "start": 94, "end": 108}, {"term": "advanced cancer", "negation": "affirmed", "UMLS": {}, "start": 114, "end": 129}, {"term": "COVID-19", "negation": "affirmed", "UMLS": {}, "start": 194, "end": 202}, {"term": "Elderly", "negation": "affirmed", "UMLS": {}, "start": 104, "end": 111}], "Comparison Results": [], "Study Arm 1 Results": [], "Study Arm 2 Results": [], "Hypothesis": []}, "Sentence-level breakdown": [{"Section": "TITLE", "Text": "Advance Care Planning : Promoting Effective and Aligned Communication in the Elderly ( ACP-PEACE ) : the study protocol for a pragmatic stepped-wedge trial of older patients with cancer .", "Evidence Elements": {"Participant": [{"term": "Planning", "negation": "affirmed", "UMLS": {}, "start": 13, "end": 21}], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "INTRODUCTION", "Text": "Advance care planning ( ACP ) is associated with improved health outcomes for patients with cancer , and its absence is associated with unfavourable outcomes for patients and their caregivers .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "INTRODUCTION", "Text": "However , older adults do not complete ACP at expected rates due to patient and clinician barriers .", "Evidence Elements": {"Participant": [{"term": "older adults", "negation": "affirmed", "UMLS": {}, "start": 10, "end": 22}], "Intervention": [{"term": "ACP", "negation": "negated", "UMLS": {}, "start": 39, "end": 42}], "Outcome": [{"term": "patient", "negation": "negated", "UMLS": {}, "start": 68, "end": 75}], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "INTRODUCTION", "Text": "We present the original design , methods and rationale for a trial aimed at improving ACP for older patients with advanced cancer and the modified protocol in response to changes brought by the COVID-19 pandemic .", "Evidence Elements": {"Participant": [{"term": "older patients", "negation": "affirmed", "UMLS": {}, "start": 94, "end": 108}, {"term": "advanced cancer", "negation": "affirmed", "UMLS": {}, "start": 114, "end": 129}, {"term": "COVID-19", "negation": "affirmed", "UMLS": {}, "start": 194, "end": 202}], "Intervention": [{"term": "modified protocol", "negation": "affirmed", "UMLS": {}, "start": 138, "end": 155}], "Outcome": [{"term": "ACP", "negation": "affirmed", "UMLS": {}, "start": 86, "end": 89}], "Observation": [{"term": "improving", "negation": "affirmed", "UMLS": {}, "start": 76, "end": 85}], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "METHODS AND ANALYSIS : The Advance Care Planning : Promoting Effective and Aligned Communication in the Elderly study is a pragmatic , stepped-wedge cluster randomised trial examining a Comprehensive ACP Program .", "Evidence Elements": {"Participant": [{"term": "Elderly", "negation": "affirmed", "UMLS": {}, "start": 104, "end": 111}], "Intervention": [{"term": "Advance Care Planning", "negation": "affirmed", "UMLS": {}, "start": 27, "end": 48}, {"term": "Comprehensive", "negation": "affirmed", "UMLS": {}, "start": 186, "end": 199}], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "The programme combines two complementary evidence-based interventions : clinician communication skills training ( VitalTalk ) and patient video decision aids ( ACP Decisions ) .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "clinician communication skills training ( VitalTalk )", "negation": "affirmed", "UMLS": {}, "start": 72, "end": 125}, {"term": "patient video decision", "negation": "affirmed", "UMLS": {}, "start": 130, "end": 152}], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "We will implement the programme at 36 oncology clinics across three unique US health systems .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "Our primary outcome is the proportion of eligible patients with ACP documentation completed in the electronic health record .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [{"term": "proportion of eligible patients with ACP documentation completed in the electronic health record", "negation": "affirmed", "UMLS": {}, "start": 27, "end": 123}], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "Our secondary outcomes include resuscitation preferences , palliative care consultations , death , hospice use and final cancer-directed therapy .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [{"term": "resuscitation preferences", "negation": "affirmed", "UMLS": {}, "start": 31, "end": 56}, {"term": "palliative care consultations", "negation": "affirmed", "UMLS": {}, "start": 59, "end": 88}, {"term": "death", "negation": "affirmed", "UMLS": {}, "start": 91, "end": 96}, {"term": "hospice use", "negation": "affirmed", "UMLS": {}, "start": 99, "end": 110}], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "From a subset of our patient population , we will collect surveys and video-based declarations of goals and preferences .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [{"term": "surveys", "negation": "affirmed", "UMLS": {}, "start": 58, "end": 65}, {"term": "video-based declarations of goals and", "negation": "affirmed", "UMLS": {}, "start": 70, "end": 107}], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "We estimate 11000 patients from the three sites will be enrolled in the study .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "ETHICS AND DISSEMINATION : Regulatory and ethical aspects of this trial include Institutional Review Board ( IRB ) approval via single IRB of record mechanism at Dana-Farber Cancer Institute , Data Use Agreements among partners and a Data Safety and Monitoring Board .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "We plan to present findings at national meetings and publish the results .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "TRIAL REGISTRATION NUMBER : NCT03609177 ; Pre-results .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "\u00a9 Author (s ) ( or their employer (s ) ) 2020 . Re-use permitted under CC BY-NC .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "No commercial re-use . See rights and permissions .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "Published by BMJ .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}]}